GlaxoSmithKline

Type
Internal restructuring
Country
Ireland
Region
Ireland; Eastern and Midland; Dublin
Location of affected unit(s)
Dublin
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
121 jobs
Number of planned job losses
Job loss
Announcement Date
4 October 2010
Employment effect (start)
Foreseen end date

Description

Pharmaceutical multinational GlaxoSmithKline has announced 121 redundancies at its plant in County Cork. GSK has attributed the job losses to declining demand for certain drugs it manufactures. The company currently employs 460 people in manufacturing and research and development at the County Cork site.

Sources

  • 4 October 2010: RTE

Citation

Eurofound (2010), GlaxoSmithKline, Internal restructuring in Ireland, factsheet number 71005, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/71005.